CellSource Co., Ltd.

2026/09/11 Updated
Market Cap: $40.9M (¥6.3B)
Stock Price: $2.06 (¥318)
Exchange Rate: 1 USD = ¥154.32

Notice of Recording of Income Tax Adjustment (Loss)

For the cumulative third quarter of the fiscal year ending October 2026, an income tax adjustment (loss) of 38 million yen is recorded. As a result, quarterly net income increases. A write-down of deferred tax assets occurred due to a reduction in carried-forward losses.

Importance:
Page Updated: September 8, 2026
IR Disclosure Date: September 8, 2026

Key Figures

  • Income tax adjustment (loss): 38 百万円
  • Quarterly net income: Unknown (Increase)
  • Period: Cumulative third quarter of the fiscal year ending October 2026 (November 1, 2025–July 31, 2026)

AI要約

Overview of Results

Due to higher-than-expected sales in the high-priority segment of contract manufacturing services, quarterly net income increased. In addition, reductions in selling, general, and administrative expenses through business selection and concentration contributed. Consequently, carried-forward losses decreased, leading to a write-down of deferred tax assets and recording an income tax adjustment (loss) of 38 million yen. The above impact is reflected in the publicly disclosed Financial Summary for the third quarter of the fiscal year ending October 2026 (Japanese accounting standards, unaudited).

Impact on shareholders and outlook

The recording of the income tax adjustment (loss) affects net income in the short term, but details on the full-year outlook and segment-specific impact are expected to be disclosed separately in the current fiscal year earnings report. The key point to monitor is whether the sales resilience and cost-reduction effects continue.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Cellsource Corporation

Company overview · Stock price · Financial data · All IR

View company page →